DNAnexus Platform

DNAnexus is a leading cloud-based SaaS company specializing in biomedical informatics and data management. Founded in 2009 by scientists from Stanford University, the brand was created to provide a scalable infrastructure for genomic research, enabling hospitals and pharmaceutical companies to process massive amounts of DNA sequence data efficiently.

The platform operates primarily through its proprietary software environment, hosted on major cloud infrastructures such as Amazon Web Services (AWS) and Microsoft Azure. As a digital technology service, its 'manufacturing' or development occurs in the United States, specifically in California, where its engineering and R&D teams are based. Over the years, DNAnexus has grown into a cornerstone of the global genomics community, partnering with major initiatives like the UK Biobank and the FDA.

Today, DNAnexus remains an independent private entity backed by significant venture capital from major technology and life science investors, including GV (formerly Google Ventures), Blackstone, and Perceptive Advisors. Its ownership structure reflects a consortium of high-profile investment firms focused on the intersection of healthcare technology and big data.